| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |